HABIT: Heparin and Aspirin on Birth in Inherited Thrombophilia, an International Multicenter Phase IIb Randomized Triple Blinded Clinical Trial
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
item.page.accessRights
Acceso abierto
item.page.other
item.page.references
Abstract
Introduction: In pregnant women with inherited thrombophilia (IT) and recurrent pregnancy loss, there is no higher-level evidence proving the beneficial effects of anticoagulation or platelet inhibiti...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Carvalho, A., Awad, C., Gallucci, A., Flores, A. P., Riva, A. L., Díaz-Gil, D., Silva, D. D., Saraceno, T. J., Rivera, O., Fricke, S., Garcia, R., Zhou, S., Bazan, M., Castellaro, M., Alencar, L., López-Blanco, P., Teixeira, E., Gonçalves, R., Etchebehere, P., . . . Hussein, N. (2022, December 21). The HABIT: Heparin and Aspirin on Birth in Inherited Thrombophilia, an International Multicenter Phase IIb Randomized Triple Blinded Clinical Trial | Principles and Practice of Clinical Research. The HABIT: Heparin and Aspirin on Birth in Inherited Thrombophilia, an International Multicenter Phase IIb Randomized Triple Blinded Clinical Trial | Principles and Practice of Clinical Research. https://doi.org/10.21801/ppcrj.2022.83.8
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
3 2,3 1,5 0,8 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026